Considering the role of four months of rifampin in the treatment of latent tuberculosis infection.
about
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TBTuberculosis, nontuberculous lung infection, pleural disorders, pulmonary function, respiratory muscles, occupational lung disease, pulmonary infections, and social issues in AJRCCM in 2004Prevalence of anti-tuberculosis drug resistance in foreign-born tuberculosis cases in the U.S. and in their countries of originNew approaches in the diagnosis and treatment of latent tuberculosis infectionThe use of anti-tuberculosis therapy for latent TB infectionRifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.Isoniazid vs. rifampin for latent tuberculosis infection in jail inmates: toxicity and adherenceUpdate in tuberculosis 2005.Treatment of tuberculosis in children.Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study.Cost-effectiveness of rifampin for 4 months and isoniazid for 9 months in the treatment of tuberculosis infection.Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.
P2860
Q24201325-5143D87E-7F17-4189-9934-F9B4ADD68A5DQ28238675-ACF31E7F-1FCA-4D3B-A02E-7F42F8814B50Q28484926-60B9B72C-39B7-4636-8D37-F7A5F4F8BA7AQ34419185-9EE5CE9E-57FA-4FDD-84D9-6FBB23B54749Q35026573-106F080D-2EE2-466C-8947-6F78A6DCDC47Q35754209-ABAFEBD2-219B-4A81-8119-012ED976976AQ35954014-9ECA3A64-DB74-4D93-B347-DECA107E20A4Q36403165-B0AF777E-0ED2-4882-9445-07FF78BE525DQ37340569-81FD6A22-ACF8-4595-9473-F7F80F7CEC41Q41657767-24142C68-2925-4EB7-97E2-B92FA34CF60FQ42376840-09E8CCA8-1887-472A-AF68-15FCE542D37BQ45935090-EC628EDC-E42D-488E-95C7-91FF4C4B4458Q45988272-6A81E9F5-E73B-4506-BD7F-E4D34D5521E5Q47133419-D1771C7E-6439-459C-A690-EF2896571A5A
P2860
Considering the role of four months of rifampin in the treatment of latent tuberculosis infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Considering the role of four m ...... latent tuberculosis infection.
@ast
Considering the role of four m ...... latent tuberculosis infection.
@en
type
label
Considering the role of four m ...... latent tuberculosis infection.
@ast
Considering the role of four m ...... latent tuberculosis infection.
@en
prefLabel
Considering the role of four m ...... latent tuberculosis infection.
@ast
Considering the role of four m ...... latent tuberculosis infection.
@en
P2093
P2860
P1476
Considering the role of four m ...... latent tuberculosis infection.
@en
P2093
Alfred Lardizabal
Christopher H Hayden
Lee B Reichman
P2860
P304
P356
10.1164/RCCM.200405-584PP
P407
P577
2004-08-05T00:00:00Z